Blog

February 21, 2019

Federal Circuit Provides Guidance on the Limits of Invalidating Under Public Use

Scott Chappell
Read More
February 14, 2019

Taking Another Look at Patent Term Adjustment: Supernus Pharmaceuticals, Inc. v. Iancu

Sangwoo Ahn
Read More
January 25, 2019

Secret Sales Remain Prior Art Under the AIA: Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.

Read More
January 9, 2019

When Double Patenting Rejections are Not Obvious: Novartis v. Breckenridge and Novartis v. Ezra

Kirsten Johnson
Read More
November 7, 2018

Patent Strategies for Beta Testing: Leveraging Provisional Patent Applications to Preserve Patent Rights for Beta Features

Aaron Johnson
Read More
October 11, 2018

PTAB Revises Claim Construction Standard

Dinesh N. Melwani
Read More
October 4, 2018

PTAB Publishes AIA Trial Practice Guide Update

Jason B. Portis
Read More
June 21, 2018

Patent-Eligibility of “Methods of Treatment,” and Possible Movement Toward Greater Eligibility

Aaron Johnson
Read More
May 2, 2018

Supreme Court Strikes Down PTAB Partial-Institution Practice—SAS Institute v. Iancu

Elissa N. Knoff
Read More
April 20, 2018

USPTO Releases Updated Patent-Eligibility Guidance Favorable to Patent Applicants

Christopher Agrawal
Read More